中国经济网北京1月5日讯荃银高科（300087）(300087.SZ)今晚发布关于中国种子集团有限公司要约收 购期限届满暨股票停牌的公告。 荃银高科于2025年12月3日披露了中国种子集团有限公司(简称"中种集团")送达的《安徽荃银高科种业 股份有限公司要约收购报告书》，中种集团向除中种集团以外的公司全体股东发出的部分要约(简称"本 次要约收购")，要约价格为11.85元/股，要约收购股份数量189,466,350股，占公司总股本的20.00%。本 次要约收购期限为2025年12月4日至2026年1月5日。 截至2026年1月5日，本次要约收购期限已届满。鉴于本次要约收购结果需进一步确认，根据《深圳证券 交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第6号——停复牌》《深圳证券 交易所创业板上市公司自律监管指南第1号——业务办理》等有关规定，经公司向深圳证券交易所申 请，公司股票(股票简称：荃银高科，股票代码：300087)自2026年1月6日(星期二)上午开市起停牌，并 将在要约收购结果公告日开市起复牌。 荃银高科表示，公司将密切关注本次要约收购相关事项的进展情况，并将根据该本公司及董事会全 ...

Core Viewpoint - BMW has initiated a significant price reduction across 31 key models, with discounts reaching up to 300,000 yuan, marking a departure from its previous stance against price wars in the luxury car market [1][4]. Group 1: Price Reduction Details - The price cuts affect a wide range of models, with reductions generally exceeding 10%, and 24 models seeing cuts over 10%, while 5 models have reductions over 20% [2]. - The model with the largest price drop is the BMW i7 M70L, which saw a reduction from 1.899 million yuan to 1.598 million yuan, a decrease of 301,000 yuan [3][4]. - The entry-level BMW 225L M Sport model's price was reduced from 259,900 yuan to 208,000 yuan, lowering the entry barrier for consumers [2]. Group 2: Market Context and Strategy - BMW's price reduction is framed as a "value upgrade" rather than a price war, indicating a strategic response to market dynamics [4]. - The luxury car market in China is undergoing rapid restructuring, with traditional German brands like BMW, Mercedes-Benz, and Audi facing declining sales, as evidenced by a 14.7% drop in BMW's sales from January to November 2025 [6]. - The rise of Chinese brands, which have seen significant sales growth, poses a challenge to established luxury brands, with companies like Hongmeng Zhixing and Zeekr achieving sales of 589,000 and 575,000 units respectively in 2025 [7][8]. Group 3: Regulatory Environment and Implications - The Chinese government has been actively regulating price wars in the automotive sector, emphasizing compliance with pricing guidelines to promote healthy market development [9]. - BMW's decision to lower prices may attract consumer interest in the short term but could undermine its brand's pricing integrity and consumer perception in the long run [9]. - The competitive landscape may prompt other luxury brands like Mercedes-Benz and Audi to reconsider their pricing strategies in response to BMW's actions, potentially reshaping the market dynamics further [10].

Core Viewpoint - The "Quanshou Night Talk" initiative in Taocai Village, Henan Province, has led to significant improvements in local governance and community engagement, fostering a cleaner and more organized environment through collaborative discussions among villagers and officials [1][2][3] Group 1: Community Engagement and Governance - The initiative encourages villagers to participate actively in discussions about local issues, leading to a more transparent and accountable governance process [2] - Topics discussed include village regulations, conflict resolution, and community projects, allowing villagers to voice their concerns and suggestions directly [2][3] - The program has established a system for tracking issues and solutions, enhancing the effectiveness of grassroots governance [2] Group 2: Implementation and Impact - Since its launch in December 2022, the "Quanshou Night Talk" has been held over ten times, becoming a platform for policy dissemination, conflict mediation, and democratic deliberation [3] - The initiative utilizes public spaces for discussions, making it accessible and engaging for the community [2] - It aims to improve the quality of rural governance and promote a culture of civility and cooperation among villagers [3]

（责任编辑：刘畅 ） 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 2026年1月5日国新办于举行新闻发布会，介绍长江经济带发展十年工作进展和成效。国家发展改革 委副主任王昌林在会上谈到，十年来，横贯东西、承接南北、通江达海的优势在长江经济带持续释放， 开放长江活力更加澎湃。我们坚持巩固提升长江黄金水道功能，加快构建沿江综合立体交通走廊，长江 水系高等级航道由0.8万公里增加到1.1万公里，干线港口货物吞吐量增长71%、达到42亿吨、稳居世界 内河第一。推进高水平对外开放，中欧（亚）班列、西部陆海新通道高质量建设，沿江9个自贸试验区 联动发展。 ...

中国经济网1月5日讯辽宁省药品监督管理局日前发布的药品质量公告显示，2批次辅酶Q10注射液抽检不合格。 根据公告，该2批次不合格辅酶Q10注射液，标示生产企业为辽宁中海康生物制药股份有限公司，生产批号为09250201、09241205，规格为2ml：5mg，不符 合项目为性状、可见异物。 据了解，性状项下常记载外观、臭、味、溶解度以及物理常数等，在一定程度上反映药品的质量特性。可见异物系指存在于注射剂、眼用液体制剂中，在规 定的目视条件下能够观察到的不溶性物质，其粒径或长度通常大于50微米。 辽宁省药品监督管理局表示，对不符合规定药品，被抽样单位所在地药品监督管理部门已采取了必要的控制措施并立案查处；对标示外省企业生产的不符合 规定药品已通报相关省级药品监管部门。 据悉，辽宁中海康生物制药股份有限公司成立于2008年6月，位于辽宁省本溪市石桥子，公司注册资金3812万余元。公司以心血管用药、抗肿瘤等为研发重 点，以注射剂的开发为首选，开发产品覆盖心脑血管、内分泌、消化、肾脏病以及风湿免疫、肝病用药等领域。2016年11月，企业实现新三板挂牌。 ...

中国经济网北京1月5日讯 国家金融监督管理总局网站昨日公布的遵义监管分局行政处罚信息公开表 （遵金罚决字〔2025〕40-45号）显示，中国人民财产保险股份有限公司遵义市播州区支公司虚列业务 宣传费用，中国人民财产保险股份有限公司遵义市汇川区支公司虚挂中介业务套取手续费。 时任中国人民财产保险股份有限公司遵义市播州区支公司经理杨江玉、时任中国人民财产保险股份有限 公司遵义市播州区支公司综合部经理邓丽对中国人民财产保险股份有限公司遵义市播州区支公司上述违 法违规行为负有责任。 时任中国人民财产保险股份有限公司遵义市汇川区支公司经理申讯、时任中国人民财产保险股份有限公 司遵义市汇川区支公司直销团队经理万启兵对中国人民财产保险股份有限公司遵义市汇川区支公司上述 违法违规行为负有责任。 | 序 | | 行政处罚决 | 主要违法 | 行政处 | 作出 | | --- | --- | --- | --- | --- | --- | | 를 | 当事人名称 | 定书文号 | 违规行为 | 罚内容 | 决定 | | | | | | | 机关 | | | 中国人民财产 保险股份有限 | 做共同决字 (2025) 40 | | ...

Core Viewpoint - Meike Home (600337.SH) resumed trading on January 5, 2026, with a closing price of 3.21 yuan, reflecting a 9.93% increase following the announcement of a planned acquisition of Shenzhen Wandeng Technology Co., Ltd. [1][2] Group 1: Transaction Details - Meike Home plans to acquire 100% equity of Wandeng Technology through a combination of issuing shares and cash payments, while also raising supporting funds from no more than 35 specific investors [2][3] - The share issuance price for the acquisition is set at 1.94 yuan per share, which is not less than 80% of the average trading price over the previous 120 trading days [3] - The total amount of supporting funds to be raised will not exceed 100% of the transaction price for the asset acquisition, with the number of shares issued capped at 30% of the company's total share capital prior to the transaction [3] Group 2: Financial Performance of Target Company - As of December 31, 2023, the total assets of Wandeng Technology were 20.63 million yuan, with total liabilities of 16.28 million yuan and shareholders' equity of 4.35 million yuan [5] - The company reported total revenues of 45.98 million yuan in 2022, 41.82 million yuan in 2023, and 33.95 million yuan in 2024, with net profits of -28.9 million yuan, -46.3 million yuan, and -86.4 million yuan respectively [5] Group 3: Strategic Implications - The acquisition is expected to facilitate Meike Home's strategic transformation, expanding new business growth points and enhancing operational quality and profitability [4]

Core Viewpoint - Haixiang New Materials (003011.SZ) is currently trading at 21.66 yuan, reflecting a decline of 1.72% and is in a state of breaking its initial public offering (IPO) price [1] Group 1: Company Overview - Haixiang New Materials was listed on the Shenzhen Stock Exchange on September 30, 2020, with an initial public offering of 18.34 million shares at a price of 38.67 yuan per share [1] - The total funds raised from the IPO amounted to 709 million yuan, with a net amount of 614 million yuan after deducting issuance costs [1] Group 2: Fund Allocation - Of the net funds raised, 475 million yuan is allocated for the construction of a production base for 20 million square meters of PVC flooring, 59.88 million yuan for the establishment of a research and development center, and 80 million yuan for working capital [1] Group 3: Issuance Costs - The total issuance costs for the IPO were 94.75 million yuan, which included underwriting and sponsorship fees of 68.67 million yuan [1] Group 4: Shareholder Returns - On May 28, 2021, Haixiang New Materials announced a stock bonus of 4 shares for every 10 shares held and a cash dividend of 3.00 yuan per 10 shares to all shareholders [1]

Core Viewpoint - Tianyu Biological (603717.SH) is currently trading at 7.68 yuan, reflecting a decline of 2.04% and is in a state of breaking its initial public offering price [1] Group 1: Company Overview - Tianyu Biological was previously known as Tianyu Ecology and will officially change its name on August 21, 2024, while retaining its stock code 603717 [1] - The company was listed on the Shanghai Stock Exchange on March 27, 2017, with an issuance of 43.1779 million shares at a price of 14.63 yuan per share [1] Group 2: Fundraising and Financials - The total amount raised from the initial public offering was 631.6927 million yuan, with a net amount of 570.1861 million yuan after expenses [2] - The total issuance costs for the IPO were 61.5066 million yuan, including an underwriting fee of 52.7196 million yuan [3] - Tianyu Biological's previous fundraising totaled 1.034 billion yuan, with a non-public offering of 48.35 million shares at a price of 8.32 yuan per share, raising 402.272 million yuan [4][5]

上市首日，四方新材盘中最高价报61.75元，为该股上市以来最高价。该股目前处于破发状态。 中国经济网北京1月5日讯 四方新材(605122.SH)今日收报12.62元，跌幅4.03%。 四方新材于2021年3月10日在上交所上市，发行数量为3,090.00万股，发行价格42.88元/股，保荐机 构为中原证券股份有限公司，保荐代表人为战晓峰、白凯。 四方新材首次公开发行股票的发行费用总计8,986.90万元，其中，保荐和承销费用7,732.69万元。 2021年5月27日，四方新材以方案实施前的公司总股本123,110,000股为基数，每股派发现金红利0.6 元（含税），以资本公积金向全体股东每股转增0.4股，共计派发现金红利73,866,000元，转增 49,244,000股，本次分配后总股本为172,354,000股。 四方新材首次公开发行股票募集资金总额132,499.20万元，扣除发行费用后募集资金净额123,512.30 万元。四方新材于2021年2月25日披露的招股说明书显示，该公司原拟募集资金123,512.30万元，拟用于 装配式混凝土预制构件项目、干拌砂浆项目、物流配送体系升级项目、补充流动资 ...